InspireMD to Report Second Quarter Financial Results on Tuesday, August 9, 2016
(firmenpresse) - BOSTON, MA -- (Marketwired) -- 08/02/16 -- (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS), a leader in embolic protection systems, announced today that it will release its financial results for the second quarter ended June 30, 2016 on Tuesday, August 9 after the market close, followed by a conference call at 4:30 p.m. ET to review results and provide a company update.
Participants should call (866) 652-5200 (United States) or (412) 317-6060 (International) and request the InspireMD call. A live webcast will be available in the Investor Relations section of the Company's website or by .
An archive of the webcast will be available approximately two hours following the call and will be accessible in the Investor Relations section of the Company's website or by . A dial-in replay of the call will also be available to those interested until August 23, 2016.
InspireMD seeks to utilize its proprietary MGuard™ with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.
InspireMD intends to pursue applications of this MicroNet™ technology in coronary, carotid (CGuard™), neurovascular, and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.
Craig Shore
Chief Financial Officer
Phone: 1-888-776-6804 FREE
Email:
David Carey
Investor Relations
(212) 867-1768
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2016 - 11:00 Uhr
Sprache: Deutsch
News-ID 486694
Anzahl Zeichen: 0
contact information:
Town:
BOSTON, MA
Kategorie:
Medical Devices
Diese Pressemitteilung wurde bisher 273 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"InspireMD to Report Second Quarter Financial Results on Tuesday, August 9, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von
InspireMD, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
